documents: FDA-2024-D-4643-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-D-4643-0002 | FDA | FDA-2024-D-4643 | Assessment of Ovarian Toxicity in Premenopausal Adults During Drug Development for Oncologic Products; Guidance for Industry - Draft Guidance | Other | Guidance | 2024-11-27T05:00:00Z | 2024 | 11 | 2024-11-27T05:00:00Z | 2025-01-28T04:59:59Z | 2025-07-23T09:00:21Z | 1 | 0 | 090000648683b3d3 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref